The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice.
about
Functional alterations of astrocytes in mental disorders: pharmacological significance as a drug targetEmerging pharmacologic treatment options for fragile X syndromeLearning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us.The pathophysiology of fragile X (and what it teaches us about synapses)Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromesReducing GBA2 Activity Ameliorates Neuropathology in Niemann-Pick Type C MiceTherapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and BackProgress toward therapeutic potential for AFQ056 in Fragile X syndrome.From FMRP function to potential therapies for fragile X syndrome.Helios expression coordinates the development of a subset of striatopallidal medium spiny neuronsFenobam promoted the neuroprotective effect of PEP-1-FK506BP following oxidative stress by increasing its transduction efficiency.Extinction of an instrumental response: a cognitive behavioral assay in Fmr1 knockout mice.Deficit in motor training-induced clustering, but not stabilization, of new dendritic spines in FMR1 knock-out miceFmr1 KO and fenobam treatment differentially impact distinct synapse populations of mouse neocortex.Cerebellar control of gait and interlimb coordination.Altered structural and functional synaptic plasticity with motor skill learning in a mouse model of fragile X syndrome.RNA-binding profiles of Drosophila CPEB proteins Orb and Orb2.Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis.Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development.Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus biasGenetic and Pharmacological Reversibility of Phenotypes in Mouse Models of Autism Spectrum Disorder.Synaptic vesicle dynamic changes in a model of fragile X.Behavioral abnormalities in the Fmr1-KO2 mouse model of fragile X syndrome: The relevance of early life phases.Negative versus positive allosteric modulation of metabotropic glutamate receptors (mGluR5): indices for potential pro-cognitive drug properties based on EEG network oscillations and sleep-wake organization in rats.Of Men and Mice: Modeling the Fragile X Syndrome.Neural Dynamics of Autistic Repetitive Behaviors and Fragile X Syndrome: Basal Ganglia Movement Gating and mGluR-Modulated Adaptively Timed Learning.
P2860
Q26798948-D23E3144-AF8D-42BC-A3C7-561A40BD6498Q26829152-0EF9FDE2-167C-444E-8937-52C7FDC6FEB2Q26866506-870D31A7-467C-4E62-9D2D-4B627D6E7B49Q27010675-A1B5BD9A-EFB9-4A67-824F-ADD64ACA0CDFQ27023257-361A1B8C-1444-4E72-AFED-C481BC482A94Q27300108-D2965EF0-62BF-4208-B850-2F279D90907AQ27337360-8BA33742-983A-43D1-8BA5-9D6AC716E65DQ30383696-D6AADC13-4C37-4850-B5A4-F5090E25089DQ30410502-C5A9613C-23E7-4D6A-832D-6FE02CF8BF1BQ33588405-43191542-E651-435A-B2C2-C019B1399BEAQ34049298-B61FD5E4-6BB7-4789-8C18-5231DFDFF7EAQ34276734-128E4608-7A48-4A1F-B1D9-005F60F3EF05Q35581839-3DB23AF8-CC48-4987-A559-14917FCD1B39Q35776690-CD284397-7B8A-4764-9827-11973520F6C8Q36074608-C04DCCA4-D384-44BA-927F-C791CCA792FBQ37381870-97BAE719-70D2-4512-ACAD-9AF80CD3989FQ37417866-D66A8440-09B4-4141-8B15-51B8F302BD82Q37679933-1DA76FB4-BD46-4904-BCF1-E075A6C2FF79Q38162720-85EC7398-E7E9-43AF-95E2-B8847BDFBEE1Q38567309-902F9E98-AD57-400C-8225-2BC05189B8CCQ38678066-BBACB66D-9C9E-4F97-9244-649176EEC98EQ38693916-AD7922AF-4C7D-4D19-B694-7ABE11FFF068Q38738836-87553B5D-B6AC-425A-B590-A539A36A5E59Q48022620-203C260B-EB05-4E0E-9508-DEB819F58EB9Q53422584-1BA04236-5EDB-4B51-8205-674CAE421823Q53834234-F9A1C73D-0F65-424A-AEE4-C5B587EF14BA
P2860
The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The effect of an mGluR5 inhibi ...... n impairments in Fmr1 KO mice.
@ast
The effect of an mGluR5 inhibi ...... n impairments in Fmr1 KO mice.
@en
type
label
The effect of an mGluR5 inhibi ...... n impairments in Fmr1 KO mice.
@ast
The effect of an mGluR5 inhibi ...... n impairments in Fmr1 KO mice.
@en
prefLabel
The effect of an mGluR5 inhibi ...... n impairments in Fmr1 KO mice.
@ast
The effect of an mGluR5 inhibi ...... n impairments in Fmr1 KO mice.
@en
P2093
P2860
P1476
The effect of an mGluR5 inhibi ...... on impairments in Fmr1 KO mice
@en
P2093
B A Oostra
C I De Zeeuw
J W Potters
M F Vinueza Veloz
R Willemsen
S K E Koekkoek
P2860
P304
P356
10.1111/J.1601-183X.2011.00763.X
P407
P577
2012-01-19T00:00:00Z